FMR LLC 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 1:16 pm Purchase | 2025-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | FMR LLC | 16,468,419 15.000% | 5,089,212 (+44.72%) | Filing |
| 2025-10-07 3:49 pm Purchase | 2025-09-30 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | FMR LLC | 11,379,207 10.700% | 11,379,207 (New Position) | Filing |